Evidence map›Paper›PMID 42094996›Full record

ArticleASM case reports2026

Are you for real,

James Lee, Matthew D Surette, Mary Czech, Adrian M Zelazny

Abstract readCase Reports
In one paragraph

Article in ASM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

James Lee *Department of Laboratory Medicine, National Institutes of Health (NIH), Bethesda, Maryland, USA.ORCID https://orcid.org/0009-0003-9935-1301
Matthew D Surette *Department of Laboratory Medicine, National Institutes of Health (NIH), Bethesda, Maryland, USA.
Mary CzechNational Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, USA.
Adrian M ZelaznyDepartment of Laboratory Medicine, National Institutes of Health (NIH), Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0003-2847-7428

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Case Summary: A 64-year-old man with primary myelofibrosis presented for infectious disease evaluation prior to hematopoietic cell transplant (HCT). Although he had past tuberculosis (TB) exposure, he was asymptomatic, and chest CT was normal except for two stable left lower-lobe subpleural nodules noted earlier. Multiple respiratory cultures grew a modified acid-fast positive rod identified by MALDI-TOF MS and targeted sequencing as Conclusion: Despite meeting microbiologic criteria for non-tuberculous mycobacteria pulmonary disease, this case underscores that clinical and radiographic context is essential when interpreting

Indexed as

genotypic identificationMALDI-TOF MStargeted sequencingTsukamurellawhole-genome sequencing

Identifiers

PMID42094996
PMCPMC13142018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.